Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "Yes, the licensing can continue."

Im not saying TPL is cash poor at all... they might be rolling in it for all i care..

Im just saying... they have a product that generated $150 million for them ..... regardless of any companies size.... you have a product that sells.. you sell it..... maximize revenues...

Share
New Message
Please login to post a reply